associated molecules such as tumor necrosis factor (TNF), interleukin 6 (IL-6) and interleukin 10 (IL-10). Microglia are CNS-resident myeloid lineage cells that exhibit a range of activated phenotypes depending on signals present in their local environment. Microglia can cause oligodendroglial and neuronal damage via secretion of soluble factors, but have also been shown to improve remyelination in some toxininduced demyelination models. In this study, we investigated the antiinflammatory effects of DMF and MMF in primary human microglia isolated from 14 to 18 week-old fetal CNS tissue. These results were compared with responses in primary cultures of monocyte-derived macrophages. Following lipopolysaccharide (LPS) stimulation, enzymelinked immunosorbance assays (ELISA) were used to detect TNF, IL-6, and IL-10 in the culture supernatants. DMF dose-dependently suppressed secretion of TNF, IL-6, and IL-10 from microglia, but MMF did not. Macrophages exhibited robust cytokine responses to LPS that were not attenuated by DMF or MMF treatment. DMF inhibited expression of miR-155, a known inhibitor of suppressor of cytokine secretion 1 (SOCS1) in microglia, as assessed by quantitative polymerase chain reaction (qPCR). Our studies indicate that DMF inhibition of inflammatory properties may be myeloid sub-type specific and involves regulation of miR-155 expression. 
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The blood-brain barrier (BBB) functions to protect the brain from potentially-damaging pathogens and limits the infiltration of peripheral immune cells. It is a complex arrangement of astrocytes and endothelial cells which forms tight junctions and gives the structure its barrier properties. Recent evidence has highlighted the presence of peripheral immune cells in the brain parenchyma of a mouse model of Alzheimer's disease (AD; APP/PS1 mice) while disruption of the BBB and transendothelial migration of peripheral leukocytes have been reported in neuroinflammatory diseases. Enhanced expression of the proinflammatory cytokines tumour necrosis factor (TNF) alpha, interferon (IFN) gamma and interleukin (IL)-1beta has been demonstrated both in brain tissue from AD patients and APP/PS1 mice which, along with pathology, increases with age. Infiltrating macrophages have been suggested to play an important role in neuroprotection, at least in cases of acute insult, however the function they perform in a chronic inflammatory environment remains to be elucidated.
Previous data from this laboratory have demonstrated enhanced BBB permeability in several areas of the brain of APP/PS1 mice though the mechanism by which this occurs is not clear. Here, serum obtained from APP/PS1 mice, in which inflammatory cytokine concentrations were increased, negatively impacted on the membrane expression of tight junction proteins in a mouse endothelial cell line, raising the possibility that circulating factors contribute to the loss of BBB integrity in APP/PS1 mice.
The increase in BBB permeability was associated with an increase in IFNgamma concentration in hippocampus and an increase in infiltrating macrophages. To evaluate the potential responses of macrophages to such an inflammatory stimulus, we prepared bonederived macrophages (BMDMs) from wildtype (WT) and APP/PS1 mice and incubated them in the presence of IFNgamma. A genotyperelated increase in expression of several markers of the M1 activation state was observed. Previous studies have suggested that infiltrating macrophages have an important role in the clearance of plaques, however our data indicate that IFNgamma-treated BMDMs are less capable of phagocytosing amyloid-beta than those treated with IL-4. It seems likely that macrophages from APP/PS1 mice may adopt an inflammatory phenotype when they infiltrate the brain and, consequently, may no longer be effective in clearing the brain of neurotoxic amyloid-beta peptide. 
